BACKGROUND: The risk of incident high-risk human papillomavirus (HR-HPV) infection associated with recent sexual behaviors is undefined in mid-adult women (defined as women aged 25-65 years). METHODS: Triannually, 420 female online daters aged 25-65 years submitted vaginal specimens for HPV testing and completed health and sexual behavior questionnaires. The cumulative incidence of and risk factors for incident HR-HPV detection were estimated by Kaplan-Meier and Cox proportional hazards methods. RESULTS: The 12-month cumulative incidence of HR-HPV detection was 25.4% (95% confidence interval [CI], 21.3%-30.1%). Current hormonal contraceptive use was positively associated with incident HR-HPV detection. Lifetime number of male sex partners was also positively associated but only among women not recently sexually active with male partners. In analysis that adjusted for hormonal contraceptive use and marital status, women reporting multiple male partners or male partners who were new, casual, or had ≥1 concurrent partnership had a hazard of incident HR-HPV detection that was 2.81 times (95% CI, 1.38-5.69 times) that for women who reported no male sex partners in the past 6 months. Thus, among women with multiple male partners or male partners who were new, casual, or had ≥1 concurrent partnership, approximately 64% of incident HR-HPV infections were attributable to one of those partners. CONCLUSIONS: Among high-risk mid-adult women with recent new male partners, multiple male partners, or male partners who were casual or had ≥1 concurrent partnership, about two thirds of incident HR-HPV detections are likely new acquisitions, whereas about one third of cases are likely redetections of prior infections.
BACKGROUND: The risk of incident high-risk human papillomavirus (HR-HPV) infection associated with recent sexual behaviors is undefined in mid-adult women (defined as women aged 25-65 years). METHODS: Triannually, 420 female online daters aged 25-65 years submitted vaginal specimens for HPV testing and completed health and sexual behavior questionnaires. The cumulative incidence of and risk factors for incident HR-HPV detection were estimated by Kaplan-Meier and Cox proportional hazards methods. RESULTS: The 12-month cumulative incidence of HR-HPV detection was 25.4% (95% confidence interval [CI], 21.3%-30.1%). Current hormonal contraceptive use was positively associated with incident HR-HPV detection. Lifetime number of male sex partners was also positively associated but only among women not recently sexually active with male partners. In analysis that adjusted for hormonal contraceptive use and marital status, women reporting multiple male partners or male partners who were new, casual, or had ≥1 concurrent partnership had a hazard of incident HR-HPV detection that was 2.81 times (95% CI, 1.38-5.69 times) that for women who reported no male sex partners in the past 6 months. Thus, among women with multiple male partners or male partners who were new, casual, or had ≥1 concurrent partnership, approximately 64% of incident HR-HPV infections were attributable to one of those partners. CONCLUSIONS: Among high-risk mid-adult women with recent new male partners, multiple male partners, or male partners who were casual or had ≥1 concurrent partnership, about two thirds of incident HR-HPV detections are likely new acquisitions, whereas about one third of cases are likely redetections of prior infections.
Authors: Sheona M Mitchell; Musa Sekikubo; Christine Biryabarema; Josaphat J K Byamugisha; Malcolm Steinberg; Jose Jeronimo; Deborah M Money; Jan Christilaw; Gina S Ogilvie Journal: Am J Obstet Gynecol Date: 2013-08-30 Impact factor: 8.661
Authors: Anne F Rositch; Anne E Burke; Raphael P Viscidi; Michelle I Silver; Kathryn Chang; Patti E Gravitt Journal: Cancer Res Date: 2012-09-27 Impact factor: 12.701
Authors: Khalil G Ghanem; S Deblina Datta; Elizabeth R Unger; Michael Hagensee; Judith C Shlay; Peter Kerndt; Katherine Hsu; Laura A Koutsky Journal: Sex Transm Infect Date: 2011-08 Impact factor: 3.519
Authors: Maribel Almonte; Isabel Dos Santos Silva; Akua Asare; Clare Gilham; Alexandra Sargent; Andrew Bailey; Andrew Turner; Mina Desai; Henry C Kitchener; Julian Peto Journal: J Med Virol Date: 2011-04-22 Impact factor: 2.327
Authors: Marc T Goodman; Yurii B Shvetsov; Katharine McDuffie; Lynne R Wilkens; Xuemei Zhu; Pamela J Thompson; Lily Ning; Jeffrey Killeen; Lori Kamemoto; Brenda Y Hernandez Journal: Cancer Res Date: 2008-11-01 Impact factor: 12.701
Authors: Rachel L Winer; Long Fu Xi; Zhenping Shen; Joshua E Stern; Laura Newman; Qinghua Feng; James P Hughes; Laura A Koutsky Journal: Int J Cancer Date: 2013-10-18 Impact factor: 7.396
Authors: Sharon Ma; Joshua E Stern; Qinghua Feng; James P Hughes; Stephen E Hawes; Rachel L Winer Journal: J Med Virol Date: 2017-07-25 Impact factor: 2.327
Authors: Eduardo Lazcano-Ponce; Staci L Sudenga; B Nelson Torres; Mark Stoler; Leith León-Maldonado; Betania Allen-Leigh; Héctor Posso; Manuel Quiterio; María Del Pilar Hernández-Nevarez; Jorge Salmerón; Anna R Giuliano Journal: Salud Publica Mex Date: 2018 Nov-Dec